What Are the Risk Factors and Management Options for Infection After Reconstruction With Massive Bone Allografts?-Reference-Cited by-同舟云学术

What Are the Risk Factors and Management Options for Infection After Reconstruction With Massive Bone Allografts?

Published:2016-03 Issue:3 Volume:474 Page:669-673
ISSN:0009-921X
Container-title:Clinical Orthopaedics & Related Research
language:en
Short-container-title:

Author:

Aponte-Tinao Luis A.,Ayerza Miguel A.,Muscolo Luis D.,Farfalli Germán L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Orthopedics and Sports Medicine,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11999-015-4353-3.pdf

Reference7 articles.

1. Infection of massive bone allografts.;Dick;Clin Orthop Relat Res,1994

2. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma.;Gebhardt;Clin Orthop Relat Res,1991

3. Infections after massive bone allografts in surgery of bone tumors of the limbs. Incidence, contributing factors, therapeutic problems.;Hernigou;Rev Chir Orthop Reparatrice Appar Mot,1991

4. Infection in bone allografts. Incidence, nature, and treatment.;Lord;J Bone Joint Surg Am,1988

5. Infection in massive bone allografts sterilized by radiation.;Loty;Int Orthop,1994

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graft Infections in Biologic Reconstructions in the Oncologic Setting: A Systematic Review of the Literature;Journal of Clinical Medicine;2024-08-08

2. Fabrication of 3D-Printed Scaffolds with Multiscale Porosity;ACS Omega;2024-06-28

3. The Uniform Distribution of Hydroxyapatite in a Polyurethane Foam-Based Scaffold (PU/HAp) to Enhance Bone Repair in a Calvarial Defect Model;International Journal of Molecular Sciences;2024-06-11

4. Infection of surgery for bone and soft tissue sarcoma with biological reconstruction: Data from the Japanese nationwide bone tumor registry;Journal of Orthopaedic Science;2024-05

5. Long-term outcomes of intercalary allograft reconstruction for primary malignant bone tumors in lower extremities;2024-01-08